Publicaciones en colaboración con investigadoras/es de Hospital Clinic Barcelona (14)

2021

  1. European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain

    Antibiotics, Vol. 10, Núm. 1, pp. 1-15

2016

  1. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: Results of the Spanish follow-up multicenter study

    Journal of Gastroenterology and Hepatology (Australia), Vol. 31, Núm. 5, pp. 953-958

2014

  1. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337

  2. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4

2012

  1. COGENT (COlorectal cancer GENeTics) revisited

    Mutagenesis, Vol. 27, Núm. 2, pp. 143-151

2011

  1. Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)

    Scandinavian Journal of Gastroenterology, Vol. 46, Núm. 2, pp. 236-246

2010

  1. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

2008

  1. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients

    Journal of Medical Genetics, Vol. 45, Núm. 9, pp. 557-563

  2. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding

    Alimentary Pharmacology and Therapeutics

2007

  1. Effects of long-term cyclo-oxygenase 2 selective and acid inhibition on Barrett's oesophagus

    Alimentary Pharmacology and Therapeutics, Vol. 26, Núm. 6, pp. 913-923

  2. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding

    Helicobacter, Vol. 12, Núm. 4, pp. 279-286

  3. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer

    Gut, Vol. 56, Núm. 12, pp. 1714-1718

2004

  1. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in Southern Europe

    Helicobacter, Vol. 9, Núm. 3, pp. 249-254

2002

  1. Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen

    Alimentary Pharmacology and Therapeutics, Vol. 16, Núm. 3, pp. 577-586